BNP Paribas Financial Markets’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,584
Closed -$51.8K 4209
2020
Q3
$51.8K Sell
1,584
-2,856
-64% -$91.8K ﹤0.01% 3452
2020
Q2
$130K Buy
+4,440
New +$125K ﹤0.01% 2663
2020
Q1
Sell
-20
Closed -$636 4441
2019
Q4
$636 Sell
20
-3,716
-99% -$104K ﹤0.01% 4243
2019
Q3
$91.7K Buy
3,736
+1,328
+55% +$33.8K ﹤0.01% 3163
2019
Q2
$63.3K Buy
+2,408
New +$59.7K ﹤0.01% 3280

Other funds holding RXL

BNP Paribas Financial Markets's RXL Position: Q4 2020 in Review

BNP Paribas Financial Markets sold out of ProShares Ultra Health Care (RXL) in Q4 2020, closing a stake of 1,584 shares — an estimated $51.8K sold.

BNP Paribas Financial Markets first reported a position in RXL in Q2 2019 and held it in 5 quarters. The position peaked at $130K in Q2 2020. 17 funds tracked by Wall St. Rank hold RXL as of Q4 2020.

  • BNP Paribas Financial Markets reported no remaining ProShares Ultra Health Care position as of Q4 2020 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 1,584 ProShares Ultra Health Care shares in Q4 2020, an estimated $51.8K.
  • BNP Paribas Financial Markets first reported a position in ProShares Ultra Health Care in Q2 2019 and held it in 5 quarters.
  • BNP Paribas Financial Markets's ProShares Ultra Health Care position peaked at $130K in Q2 2020.
  • 17 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q4 2020.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2020, filed 10 Feb 2021.